| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |